PATENT CLAIM ANALYSIS

Application Number: 16172503
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["424", "185100"]

Abstract:
Compositions, methods of use, and pharmaceutical preparations useful for modulation of immune responses are disclosed herein. In one embodiment a composition is extracted from immune organs or leukocytes derived from members of the chondrichthyes family through dialysis. Said immune modulator is useful for treatment of conditions requiring stimulations or regulation of immunity. In one embodiment, said immunomodulator controls T cell activation by modulation of cytokine production.

Claim (Index 7):
The composition of  claim 1 , wherein said immune cells are obtained from a source that is autologous, allogeneic, or xenogeneic to the recipient.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.40385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10280627', '09771263', '13877536', '11935147', '10490949']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7304292417355145
- 35 USC 102 Novelty (BERT): 0.4740133448455114
- Combined Prediction Score: 0.7047876520465143
- Mean Citation Score: 166.67962999999995
- Max Citation Score: 179.09024
- Similarity Product: 138.8667184833336

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test